Steven Cohen Acorda Therapeutics Inc Transaction History

Point72 Asset Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.3 - $1.67 $139,282 - $775,340	-464,276 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.3 - $4.71 $8,947 - $18,321	-3,890 Reduced 0.83%	464,276 $1.11 Million
Q3 2021 Nov 15, 2021	SELL	$3.36 - $4.79 $1.41 Million - $2.02 Million	-420,733 Reduced 47.33%	468,166 $2.15 Million
Q2 2021 Aug 16, 2021	SELL	$3.61 - $5.23 $9,844 - $14,262	-2,727 Reduced 0.31%	888,899 $4.24 Million
Q1 2021 May 17, 2021	BUY	$3.8 - $8.04 $3.39 Million - $7.17 Million	891,626 New	891,626 $4.34 Million

133K

Ticker ACOR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 24,338,400
Market Cap $6.33M
Description
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.